Copyright
©The Author(s) 2022.
World J Clin Cases. Mar 16, 2022; 10(8): 2497-2503
Published online Mar 16, 2022. doi: 10.12998/wjcc.v10.i8.2497
Published online Mar 16, 2022. doi: 10.12998/wjcc.v10.i8.2497
Figure 1 Results of chest computed tomography.
A and B: Before second-line chemotherapy; C and D: After two cycles of treatment; E and F: After six cycles of treatment; G and H: At last follow-up.
- Citation: Yan FF, Jiang Q, Ru B, Fei XJ, Ruan J, Zhang XC. Metastatic urothelial carcinoma harboring ERBB2/3 mutations dramatically respond to chemotherapy plus anti-PD-1 antibody: A case report. World J Clin Cases 2022; 10(8): 2497-2503
- URL: https://www.wjgnet.com/2307-8960/full/v10/i8/2497.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i8.2497